BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17969346)

  • 41. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
    Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
    Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula.
    Shinotoh H; Shimada H; Kokubo Y; Tagai K; Niwa F; Kitamura S; Endo H; Ono M; Kimura Y; Hirano S; Mimuro M; Ichise M; Sahara N; Zhang MR; Suhara T; Higuchi M
    Neurology; 2019 Jan; 92(2):e136-e147. PubMed ID: 30530797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological study of amyotrophic lateral sclerosis and parkinsonism-dementia complex in Kii peninsula, Japan.
    Shindo A; Ueda Y; Kuzuhara S; Kokubo Y
    BMC Neurol; 2014 Jul; 14():151. PubMed ID: 25041813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Essential feature of the neuropathological findings in ALS of Guam].
    Oyanagi K; Hashimoto T
    Brain Nerve; 2007 Oct; 59(10):1075-82. PubMed ID: 17969347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of Mutant Ubiquitin and Proteostasis Impairment in Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex Brains.
    Verheijen BM; Morimoto S; Sasaki R; Oyanagi K; Kokubo Y; Kuzuhara S; van Leeuwen FW
    J Neuropathol Exp Neurol; 2020 Aug; 79(8):902-907. PubMed ID: 32647880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Changes in the incidence and clinical features of ALS in the Koza, Kozagawa, and Kushimoto area of the Kii Peninsula--from the 1960s to the 2000s (follow-up study)].
    Kihira T; Yoshida S; Murata K; Ishiguti H; Kondo T; Kohmoto J; Okamoto K; Kokubo Y; Kuzuhara S
    Brain Nerve; 2010 Jan; 62(1):72-80. PubMed ID: 20112794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy.
    Tsuji K; Nakayama Y; Taruya J; Ito H
    J Neuropathol Exp Neurol; 2024 Jan; 83(2):79-93. PubMed ID: 38193356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold.
    Qi C; Verheijen BM; Kokubo Y; Shi Y; Tetter S; Murzin AG; Nakahara A; Morimoto S; Vermulst M; Sasaki R; Aronica E; Hirokawa Y; Oyanagi K; Kakita A; Ryskeldi-Falcon B; Yoshida M; Hasegawa M; Scheres SHW; Goedert M
    Proc Natl Acad Sci U S A; 2023 Dec; 120(51):e2306767120. PubMed ID: 38100415
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of ubiquitin immunoreactivity of hippocampal granular cells in amyotrophic lateral sclerosis with dementia, Guamanian amyotrophic lateral sclerosis and Guamanian parkinsonism-dementia complex.
    Ikemoto A; Hirano A; Akiguchi I; Kimura J
    Acta Neuropathol; 1997 Mar; 93(3):265-70. PubMed ID: 9083558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea).
    Spencer PS; Palmer VS; Ludolph AC
    Mov Disord; 2005 Aug; 20 Suppl 12():S119-26. PubMed ID: 16092101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic Strategies and Metal-Induced Oxidative Stress: Application of Synchrotron Radiation Microbeam to Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan.
    Yoshida S
    Front Neurol; 2022; 13():884439. PubMed ID: 35837234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989.
    Waring SC; Esteban-Santillan C; Reed DM; Craig UK; Labarthe DR; Petersen RC; Kurland LT
    Neuroepidemiology; 2004; 23(4):192-200. PubMed ID: 15272222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kii ALS dementia.
    Yase Y; Yoshida S; Kihira T; Wakayama I; Komoto J
    Neuropathology; 2001 Jun; 21(2):105-9. PubMed ID: 11396674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disappearance of ALS from Guam: implications for exogenous causes].
    Chen KM
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1549-53. PubMed ID: 8752460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitrative Stress and Tau Accumulation in Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) in the Kii Peninsula, Japan.
    Hata Y; Ma N; Yoneda M; Morimoto S; Okano H; Murayama S; Kawanishi S; Kuzuhara S; Kokubo Y
    Front Neurosci; 2017; 11():751. PubMed ID: 29403345
    [No Abstract]   [Full Text] [Related]  

  • 57. The ALS/PDC syndrome of Guam: potential biomarkers for an enigmatic disorder.
    McGeer PL; Steele JC
    Prog Neurobiol; 2011 Dec; 95(4):663-9. PubMed ID: 21527311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam].
    Okumura H; Tashiro K
    Nihon Rinsho; 2004 Jan; 62 Suppl():136-40. PubMed ID: 15011336
    [No Abstract]   [Full Text] [Related]  

  • 59. Kampō medicine and Muro disease (Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex).
    Spencer PS; Palmer VS; Kihira T; Yoshida S; Reis J; Yabushita M; Yase Y
    eNeurologicalSci; 2020 Mar; 18():100230. PubMed ID: 32090178
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes.
    Leventoux N; Morimoto S; Ishikawa M; Nakamura S; Ozawa F; Kobayashi R; Watanabe H; Supakul S; Okamoto S; Zhou Z; Kobayashi H; Kato C; Hirokawa Y; Aiba I; Takahashi S; Shibata S; Takao M; Yoshida M; Endo F; Yamanaka K; Kokubo Y; Okano H
    Acta Neuropathol; 2024 May; 147(1):84. PubMed ID: 38750212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.